BR0014016A - Método para separar um composto de alto peso molecular contendo lactona - Google Patents

Método para separar um composto de alto peso molecular contendo lactona

Info

Publication number
BR0014016A
BR0014016A BR0014016-3A BR0014016A BR0014016A BR 0014016 A BR0014016 A BR 0014016A BR 0014016 A BR0014016 A BR 0014016A BR 0014016 A BR0014016 A BR 0014016A
Authority
BR
Brazil
Prior art keywords
molecular weight
high molecular
weight compound
separating
mixture
Prior art date
Application number
BR0014016-3A
Other languages
English (en)
Other versions
BR0014016B1 (pt
Inventor
Tomoji Higaki
Takashi Yoshiyasu
Norihiro Hashimoto
Keiji Honda
Hiroshi Hatanaka
Michio Yamashita
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of BR0014016A publication Critical patent/BR0014016A/pt
Publication of BR0014016B1 publication Critical patent/BR0014016B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

"MéTODO PARA SEPARAR UM COMPOSTO DE ALTO PESO MOLECULAR CONTENDO LACTONA". Método para separar um composto de alto peso molecular contendo lactona, compreendendo submeter uma mistura de um composto de alto peso molecular contendo lactona tendo, como sua cadeia lateral, pelo menos um de um grupo alquenila inferior e de um grupo alcoxi inferior e seu(s) composto(s) análogo(s) a qualquer uma ou a ambas as etapas, em qualquer ordem, de uma etapa (A) para adsorver a mistura numa resina de adsorção não-iónica e eluir com um solvente aquoso contendo íons de prata, e uma etapa para adsorver a mistura numa alumina ativa básica e eluir com um solvente orgânico para separar cada um dos compostos.
BRPI0014016-3A 1999-09-08 2000-09-05 método para separar um composto de alto peso molecular contendo lactona. BR0014016B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11/253813 1999-09-08
JP25381399 1999-09-08
PCT/JP2000/006023 WO2001018007A2 (en) 1999-09-08 2000-09-05 Method for separating lactone-containing high-molecular weight compounds

Publications (2)

Publication Number Publication Date
BR0014016A true BR0014016A (pt) 2002-05-21
BR0014016B1 BR0014016B1 (pt) 2011-07-12

Family

ID=17256507

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0014016-3A BR0014016B1 (pt) 1999-09-08 2000-09-05 método para separar um composto de alto peso molecular contendo lactona.

Country Status (24)

Country Link
US (2) US6576135B1 (pt)
EP (1) EP1210351B1 (pt)
JP (1) JP3925198B2 (pt)
CN (1) CN1195760C (pt)
AR (1) AR025598A1 (pt)
AT (1) ATE263773T1 (pt)
AU (1) AU779331B2 (pt)
BR (1) BR0014016B1 (pt)
CA (1) CA2384440C (pt)
CZ (1) CZ302625B6 (pt)
DE (1) DE60009723T2 (pt)
DK (1) DK1210351T3 (pt)
ES (1) ES2214307T3 (pt)
HK (1) HK1048991A1 (pt)
HU (1) HU230126B1 (pt)
MX (1) MXPA02002370A (pt)
NO (1) NO328422B1 (pt)
NZ (1) NZ517473A (pt)
PL (1) PL195650B1 (pt)
PT (1) PT1210351E (pt)
RU (1) RU2245338C2 (pt)
TR (1) TR200200593T2 (pt)
TW (1) TW553946B (pt)
WO (1) WO2001018007A2 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW553946B (en) * 1999-09-08 2003-09-21 Fujisawa Pharmaceutical Co Method for separating lactone-containing high-molecular weight compounds
US7452692B2 (en) 2002-02-13 2008-11-18 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Method for extracting a macrolide from biomatter
PL374059A1 (en) 2002-02-13 2005-09-19 Teva Gyogyszergyar Reszvenytarsasag Method for extracting a macrolide from biomatter
ES2297481T3 (es) * 2003-07-24 2008-05-01 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Metodo para purificar macrolidos.
EP1697383B1 (en) * 2003-12-05 2014-04-23 Biocon Limited Process for the purification of tacrolimus
EP1756290B1 (en) * 2004-04-12 2016-05-04 Biocon Limited Streptomyces sp. bicc 7522 and its use for the production of macrolides
MX2007002808A (es) * 2004-09-10 2007-10-10 Ivax Pharmaceuticals Sro Proceso para el aislamiento de tacrolimus cristalino.
ITMI20042098A1 (it) * 2004-11-03 2005-02-03 Antibioticos Spa Processo per la purificazione di tacrolimus
WO2006060617A1 (en) * 2004-12-01 2006-06-08 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Ascomycin crystalline forms and preparation thereof
WO2006069333A1 (en) * 2004-12-22 2006-06-29 Teva Gyógyszergyár Zàrtköruen Muködo Rèszvènytàrsasàg Method of purifying macrolides
JP2007527434A (ja) * 2005-01-05 2007-09-27 テバ ジョジセルジャール ザ−トケルエン ムケド レ−スベニュタ−ルシャシャ−グ 非晶質タクロリマス及びその調製
WO2007013017A1 (en) * 2005-07-29 2007-02-01 Ranbaxy Laboratories Limited A process for purification of macrolides
ITMI20051549A1 (it) * 2005-08-05 2007-02-06 Antibioticos Spa Purificazione del tacrolimus su supporti dimorigine vegetale
EP1896488B1 (en) * 2006-03-15 2010-05-19 TEVA Gyógyszergyár Zártkörüen Müködö Részvénytársaság Process for purifying tacrolimus
US20080000834A1 (en) * 2006-03-15 2008-01-03 Ladislav Cvak Process for purifying Tacrolimus
JP5602626B2 (ja) * 2007-06-29 2014-10-08 アーティフィシャル マッスル，インク． 感覚性フィードバック用途のための電気活性ポリマートランスデューサー
KR101022067B1 (ko) 2008-05-30 2011-03-17 이연제약주식회사 고순도 타크로리무스의 회수방법
KR100910165B1 (ko) 2008-09-18 2009-07-30 (주) 제노텍 은 이온 용액 추출을 이용한 불포화 알킬기를 가진 락톤 화합물 정제방법
WO2011163600A2 (en) 2010-06-25 2011-12-29 Apt Pharmaceuticals, Inc. Tacrolimus compositions for aerosol administration
ES2624229T3 (es) 2012-07-06 2017-07-13 Godo Shusei Co., Ltd. Método para separar un compuesto macrólido ciclico
RU2694354C1 (ru) * 2018-09-25 2019-07-11 Закрытое акционерное общество "БиоХимМак СТ" Способ сорбционно-хроматографического выделения и очистки такролимуса

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8406218D0 (en) * 1984-03-09 1984-04-11 Glaxo Group Ltd Process
AU600187B2 (en) * 1987-12-15 1990-08-02 Unilever Plc Process for concentrating lactones, as well as the use of the concentrate thus obtained for flavouring foodstuffs
NO176766C (no) 1989-02-07 1995-05-24 Meiji Seika Kaisha Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet
JPH03191788A (ja) 1989-12-19 1991-08-21 Nippon Kayaku Co Ltd 新規抗生物質ｎｋ１５５１４１およびその製造法
TW553946B (en) * 1999-09-08 2003-09-21 Fujisawa Pharmaceutical Co Method for separating lactone-containing high-molecular weight compounds

Also Published As

Publication number Publication date
TW553946B (en) 2003-09-21
DE60009723D1 (de) 2004-05-13
CN1195760C (zh) 2005-04-06
JP2003508536A (ja) 2003-03-04
NZ517473A (en) 2004-01-30
US6881341B2 (en) 2005-04-19
HUP0203196A2 (hu) 2002-12-28
MXPA02002370A (es) 2002-08-20
BR0014016B1 (pt) 2011-07-12
NO20021024D0 (no) 2002-03-01
HU230126B1 (hu) 2015-08-28
US6576135B1 (en) 2003-06-10
CA2384440C (en) 2009-02-17
ATE263773T1 (de) 2004-04-15
DK1210351T3 (da) 2004-08-02
US20030168409A1 (en) 2003-09-11
EP1210351B1 (en) 2004-04-07
CZ302625B6 (cs) 2011-08-10
CZ2002860A3 (cs) 2002-08-14
JP3925198B2 (ja) 2007-06-06
CN1373764A (zh) 2002-10-09
AR025598A1 (es) 2002-12-04
AU779331B2 (en) 2005-01-20
EP1210351A2 (en) 2002-06-05
HK1048991A1 (en) 2003-04-25
PT1210351E (pt) 2004-08-31
NO328422B1 (no) 2010-02-15
HUP0203196A3 (en) 2003-12-29
NO20021024L (no) 2002-05-02
RU2245338C2 (ru) 2005-01-27
WO2001018007A2 (en) 2001-03-15
TR200200593T2 (tr) 2002-07-22
DE60009723T2 (de) 2005-04-28
ES2214307T3 (es) 2004-09-16
WO2001018007A3 (en) 2001-07-26
PL353802A1 (en) 2003-12-01
PL195650B1 (pl) 2007-10-31
CA2384440A1 (en) 2001-03-15
AU6871300A (en) 2001-04-10

Similar Documents

Publication Publication Date Title
BR0014016A (pt) Método para separar um composto de alto peso molecular contendo lactona
BR0011597A (pt) Método para separar compostos orgânicos análogos e resina de troca iÈnica
ES551607A0 (es) Procedimiento para la rotuclacion de material organico de peso molecular alto.
WO2001007915A8 (en) Layered device with capture regions for cellular analysis
BR9708786A (pt) Composição fotrocrÈmica e método para melhorar a fadiga à luz de uma composição fotocrÈmica
LU91758I2 (fr) Denosumab et ses dérivés pharmaceutiquement acceptables (PROLIA®)
PT96379A (pt) Processo de preparacao de ciclopropil-n-hidroxi-ureias,-carboxamidas e n-acil-n-hidroxiaminas substituidas e de composicoes farmaceuticas
IT1240093B (it) Dispositivo ammortizzatore di torsione ad ammortizzatore dinamico, in particolare per autoveicoli.
DE3775389D1 (de) Verwendung von interleukin-1-proteinen gegen arthritis.
MX9102117A (es) Metodo para el tratamiento de nematodos en terreno, empleando furfural.
DE3764481D1 (de) Drehzapfenlagerblock fuer falttueren.
DE69015572D1 (de) Vorrichtung zur aktiven Dämpfung von Schwingungen.
EA200000092A1 (ru) Противоаллергические средства
ES2185024T3 (es) Procedimiento que permite mejorar el rendimiento de un reactivo inmunologico en un dosificado inmunologico.
FR2656174B1 (fr) Procede et dispositif de compensation de la derive en courant dans un circuit integre mos, et circuit integre en resultant.
PT77153B (de) Drehzapfenlager fuer tueren insbesondere fuer pendeltueren
FR2674876B1 (fr) Joint routier, notamment pour ponts, et son procede de fixation.
KR920019355A (ko) 불안증 치료용 상승작용성 혼합물
FR2704312B1 (fr) Procede et ,dispositif pour la programmation inductive d'une temporisation.
RU2001187C1 (ru) Устройство дл уплотнени откосной и междупутной зон балластной призмы
DK0384416T3 (da) Farmaceutisk sammensætning indeholdende hydantoinderivat
FR2651158B1 (fr) Dispositif d'extraction hydraulique de matieres mises en suspension.
FR2641206B1 (fr) Procede de fixation des poussieres par matieres organiques en suspension
FR2635330B1 (fr) Composition de liant bitumineux emulsifie en phase aqueuse, son procede de fabrication, et application dans le domaine routier
FR2669042B1 (fr) Procede electrochimique de preparation de trisulfures organiques.

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP)

Free format text: TRANSFERIDO POR FUSAO DE: FUJISAWA PHARMACEUTICAL CO., LTD.

B25D Requested change of name of applicant approved

Owner name: ASTELLAS PHARMA INC. (JP)

Free format text: ALTERADO DE: YAMANOUCHI PHARMACEUTICAL CO., LTD.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 12/07/2011, OBSERVADAS AS CONDICOES LEGAIS.

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 12.07.2021